Literature DB >> 14751416

Perspectives for the development of animal models of bipolar disorder.

Rodrigo Machado-Vieira1, Flavio Kapczinski, Jair C Soares.   

Abstract

Bipolar disorder (BD) has been a particularly challenging illness for the development of adequate animal models for neurobiological studies. These difficulties are largely related to the peculiar clinical characteristics of this illness, with an intriguing alternation of mania, depression, euthymia, and mixed states. The etiology and brain mechanisms involved in this several mental illness remain unknown. Preclinical studies with animal models of mania or depression have been developed to evaluate the potential efficacy of new psychotropic drugs and generate information concerning the biochemical effects of these drugs on specific targets. These models try to mimic the behavioral components of mania and depression in human subjects and examine the pharmacological responses and mechanisms of action of potentially new therapeutic agents. The main limitation is that there is currently no model that would mimic mood cyclicity, which is a hallmark feature of BD. Thus, these models do not represent valid paradigms for the study of this illness, because they do not address key questions regarding cyclicity. In this review, we propose that new genetics approaches involving potential animal models of BD are a promising new area for further development.

Entities:  

Mesh:

Year:  2004        PMID: 14751416     DOI: 10.1016/j.pnpbp.2003.10.015

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  38 in total

1.  Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.

Authors:  Jos Prickaerts; Dieder Moechars; Kim Cryns; Ilse Lenaerts; Hansfried van Craenendonck; Ilse Goris; Guy Daneels; J Adriaan Bouwknecht; Thomas Steckler
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

2.  Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.

Authors:  Gislaine T Rezin; Camila B Furlanetto; Giselli Scaini; Samira S Valvassori; Cinara L Gonçalves; Gabriela K Ferreira; Isabela C Jeremias; Wilson R Resende; Mariane R Cardoso; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-15       Impact factor: 5.590

Review 3.  Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Authors:  Jared W Young; Davide Dulcis
Journal:  Eur J Pharmacol       Date:  2015-03-23       Impact factor: 4.432

Review 4.  Reconsidering the association between the major histocompatibility complex and bipolar disorder.

Authors:  Thalita Cristina Figueiredo; João Ricardo Mendes de Oliveira
Journal:  J Mol Neurosci       Date:  2011-10-11       Impact factor: 3.444

5.  Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid.

Authors:  Rose Mary Carvalho Pinheiro; Maria Noêmia Martins de Lima; Gabriel Rodrigo Fries; Vanessa Athaíde Garcia; Juliana Presti-Torres; Luis Henrique Hallmenschlager; Luisa Azambuja Alcalde; Rafael Roesler; Monica Levy Andersen; João Quevedo; Flávio Kapczinski; Nadja Schröder
Journal:  J Neural Transm (Vienna)       Date:  2012-01-05       Impact factor: 3.575

6.  Antipsychotic-like effects of a neurotensin receptor type 1 agonist.

Authors:  Chelsea A Vadnie; Jennifer Ayers-Ringler; Alfredo Oliveros; Osama A Abulseoud; Sun Choi; Mario J Hitschfeld; Doo-Sup Choi
Journal:  Behav Brain Res       Date:  2016-02-22       Impact factor: 3.332

7.  Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test.

Authors:  Michel Bourin; Fabienne Masse; Martine Hascoët
Journal:  J Psychiatry Neurosci       Date:  2005-07       Impact factor: 6.186

Review 8.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

Review 9.  Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

Authors:  Tadafumi Kato
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Intracerebroventricular administration of ouabain alters synaptic plasticity and dopamine release in rat medial prefrontal cortex.

Authors:  Li Sui; Xiao-Jin Song; Jie Ren; Li-Hua Ju; Yan Wang
Journal:  J Neural Transm (Vienna)       Date:  2013-01-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.